DigestRedComo funciona
Red
/
Empresas
Br
No verificado

Bristol Myers Squibb

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

150 Comunicados de prensa

Ver todos los comunicados de prensa
30/07/2026
Web y redes sociales
Telefonía
Mercado de valores
Biotecnología
Salud
Ciencia
Farmacéutica
Bristol Myers Squibb Reports Second Quarter Financial Results for 2026
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
20/07/2026
Mercado laboral
Industria
Sanidad
Técnica
Farmacéutica
Tecnología
Ciencia
Biotecnología
Software
Salud
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
13/07/2026
Industria
Ciencia
Higiene alimentaria
Biotecnología
Sanidad
Farmacéutica
Salud
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
18/06/2026
Web y redes sociales
Telefonía
Finanzas
Mercado de valores
Salud
Industria
Ciencia
Farmacéutica
Biotecnología
Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
17/06/2026
Acciones y Obligaciones
Salud
Sanidad
Farmacéutica
Biotecnología
Bristol Myers Squibb Announces Dividend
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
Press Release cover image
17/06/2026
Salud
Fitness
Medicina - Varios
Bristol Myers Squibb Appoints Mayada Al-Ahmad as General Manager for Saudi Arabia & Gulf Countries
Fuente
Bristol Myers Squibb
Editor
PR News Wire
1.00
0
08/06/2026
Mariska Hargitay Partners with Bristol Myers Squibb for “Investigating Myeloma” Awareness Campaign to Honor Her Father 20 Years After Losing Him to the Disease
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
02/06/2026
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Patients with Triple-Negative Breast Cancer and Esophageal Squamous Cell Carcinoma
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
01/06/2026
Cardiología
Infancia
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Ciencia
Ir de compras
Jóvenes
Medicina - Varios
Industria
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0
01/06/2026
Industria
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Higiene alimentaria
Medicina - Varios
Bristol Myers Squibb Announces Opdivo® (nivolumab) in Combination with AVD Receives Expanded EU Label with Approval in Frontline Advanced Classical Hodgkin Lymphoma
Fuente
Bristol Myers Squibb
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0